首站-论文投稿智能助手
典型文献
Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis
文献摘要:
Dear Editor, Stem cell therapy holds enormous and revolutionary promise to treat various age-related diseases,such as diabetes,heart failure,and Parkinson's disease.However,low retention and survival rate of delivered stem cells,partially due to immuno-logical rejection,constitute major hurdles for the clinical implementation of stem cell therapy(Lei et al.,2021a).Since mounting evidence showed that several types of stem cells mainly exert their therapeutic effects through the secretion of paracrine effects,exosomes,which are released by stem cells and execute most paracrine functions,have begun to draw attention in the field(Tran and Damaser,2015).
文献关键词:
作者姓名:
Jinghui Lei;Xiaoyu Jiang;Wei Li;Jie Ren;Datao Wang;Zhejun Ji;Zeming Wu;Fang Cheng;Yusheng Cai;Zheng-Rong Yu;Juan Carlos Izpisua Belmonte;Chunyi Li;Guang-Hui Liu;Weiqi Zhang;Jing Qu;Si Wang
作者机构:
Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;University of Chinese Academy of Sciences,Beijing 100049,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute of Antler Science and Product Technology,Changchun Sci-Tech University,Changchun 130000,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;National Laboratory of Biomacromolecules,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;Department of Orthopaedics,Peking University First Hospital,Beijing 100034,China;Gene Expression Laboratory,Salk Institute for Biological Studies,La Jolla,CA,USA
文献出处:
引用格式:
[1]Jinghui Lei;Xiaoyu Jiang;Wei Li;Jie Ren;Datao Wang;Zhejun Ji;Zeming Wu;Fang Cheng;Yusheng Cai;Zheng-Rong Yu;Juan Carlos Izpisua Belmonte;Chunyi Li;Guang-Hui Liu;Weiqi Zhang;Jing Qu;Si Wang-.Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis)[J].蛋白质与细胞,2022(03):220-226
A类:
Stem,Damaser
B类:
Exosomes,from,antler,stem,cells,alleviate,mesenchymal,senescence,osteoarthritis,Dear,Editor,therapy,holds,enormous,revolutionary,promise,treat,various,age,related,diseases,such,diabetes,heart,failure,Parkinson,However,low,retention,survival,rate,delivered,partially,due,immuno,logical,rejection,constitute,major,hurdles,clinical,implementation,Lei,2021a,Since,mounting,evidence,showed,that,several,types,mainly,exert,their,therapeutic,effects,through,secretion,paracrine,exosomes,which,are,released,by,execute,most,functions,have,begun,draw,attention,field,Tran
AB值:
0.748327
相似文献
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
Ting-Ting Cao;Huan Chen;Mao Pang;Si-Si Xu;Hui-Quan Wen;Bin Liu;Li-Min Rong;Mang-Mang Li-Department of Cell Biology,School of Basic Medical Sciences,Southern Medical University,Guangzhou,Guangdong Province,China;Department of Spine Surgery,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Engineering and Technology Research of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Quality Control of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Department of Radiology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
Qing Wang;Li-Juan Song;Zhi-Bin Ding;Zhi Chai;Jie-Zhong Yu;Bao-Guo Xiao;Cun-Gen Ma-Research Center of Neurobiology,The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine,Shanxi University of Chinese Medicine,Jinzhong,Shanxi Province,China;Department of Physiology,Shanxi Medical University,Taiyuan,Shanxi Province,China;Institute of Brain Science,Shanxi Key Laboratory of Inflammatory Neurodegenerative Diseases,Shanxi Datong University,Datong,Shanxi Province,China;Department of Neurology,Datong Fifth People's Hospital,Datong,Shanxi Province,China;Institute of Neurology,Huashan Hospital,Institutes of Brain Science and State Key Laboratory of Medical Neurobiology,Fudan University,Shanghai,China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies:a phase I clinical study
Yongxian Hu;Yali Zhou;Mingming Zhang;Houli Zhao;Guoqing Wei;Wengang Ge;Qu Cui;Qitian Mu;Gong Chen;Lu Han;Tingting Guo;Jiazhen Cui;Xiaoyan Jiang;Xiujun Zheng;Shuhui Yu;Xiaolong Li;Xingwang Zhang;Mingxi Chen;Xiuju Li;Ming Gao;Kang Wang;Cheng Zu;Hao Zhang;Xiaohong He;Yanbin Wang;Dongrui Wang;Jiangtao Ren;He Huang-Bone Marrow Transplantation Center,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;Institute of Hematology,Zhejiang University,Hangzhou,Zhejiang,China;Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,Hangzhou,Zhejiang,China;Nanjing Bioheng Biotech Co.,Ltd,Nanjing,Jiangsu,China;Department of Hematology,Ruian people's Hospital,Wenzhou,Zhejiang,China;Department of Hematology,Beijing Tiantan Hospital,Capital Medical University Beijing China;Laboratory of Stem Cell Transplantation Ningbo First Hospital Ningbo,Zhejiang,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。